Sort
25,944 grants matching “neurodegeneration”
Toxicodietary and genetic determinants of susceptibility to neurodegeneration
$547,907Daniel Desire Tshala-Katumbay · Oregon Health & Science University · R01 · FY2019 · ES
Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
$547,874Irving J Bigio · Boston University (Charles River Campus) · R01 · FY2025 · AG
Repurposing FDA-approved agonists of HCAR2 as novel therapeutics for Alzheimer's Disease
$547,852Gary E. Landreth · Indiana University Indianapolis · R01 · FY2025 · AG
Clinical Core B
$547,824Daniel Weintraub · University Of Pennsylvania · U19 · FY2019 · AG
Clinical Core B
$547,823Daniel Weintraub · University Of Pennsylvania · U19 · FY2020 · AG
Impact of vascular apoE in aging and AD
$547,750Guojun Bu · Mayo Clinic Jacksonville · U19 · FY2021 · AG
Impact of vascular apoE in aging and AD
$547,750Takahisa Kanekiyo · Mayo Clinic Jacksonville · U19 · FY2022 · AG
Impact of vascular apoE in aging and AD
$547,750Takahisa Kanekiyo · Mayo Clinic Jacksonville · U19 · FY2023 · AG
Reparative effect of juvenile factors in aging and injury
$547,695Raghavan Pillai Raju · Augusta University · R01 · FY2025 · AG
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
$547,485Balaji Manicassamy · University Of Iowa · R01 · FY2023 · AI
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
$547,485Balaji Manicassamy · University Of Iowa · R01 · FY2022 · AI
Genotype-Phenotype Relationships in Fragile X Families
$547,472Randi J Hagerman · University Of California At Davis · R01 · FY2016 · HD
Proteome-wide analysis of AD-associated SNPs
$547,435Heng Zhu · Johns Hopkins University · R01 · FY2021 · AG
Mitochondria-cytoplasm interactions for cytosolic Fe-S cluster assembly
$547,334Debkumar Pain · Rbhs-New Jersey Medical School · R01 · FY2015 · GM
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
$547,318David M Holtzman · Mayo Clinic Jacksonville · U19 · FY2024 · AG
Mechanisms of Polyglutamine Neurodegeneration
$547,314Henry L Paulson · University Of Michigan At Ann Arbor · R01 · FY2016 · NS
CAA, Tau and Neurodegeneration
$547,248Cristian Lasagna-Reeves · Indiana University Indianapolis · R01 · FY2019 · AG
The Clathrin Coated Vesicle Cycle
$547,187Sandra L. Schmid · Scripps Research Institute, The · R01 · FY2010 · MH
Neuroimaging Core
$547,090Andrew J Saykin · Indiana University Indianapolis · P30 · FY2020 · AG
Systemic Mechanisms of Brain Rejuvenation
$547,071Saul A Villeda · University Of California, San Francisco · R01 · FY2024 · AG
Minocycline Immune Effects on SIV CNS Disease
$546,832M Christine Zink · Johns Hopkins University · R01 · FY2013 · MH
Neuropathology Core
$546,778Dennis William Dickson · Mayo Clinic Jacksonville · U19 · FY2022 · AG
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease
$546,768Theodore R Holman · University Of California Santa Cruz · R01 · FY2020 · AG
The role of mitochondria-glycolysis interface in developing of AD-associated neuronal mitochondrial dysfunctions.
$546,714Anatoly A Starkov · Winifred Masterson Burke Med Res Inst · P01 · FY2020 · AG
The role of mitochondria-glycolysis interface in developing of AD-associated neuronal mitochondrial dysfunctions.
$546,714Anatoly A Starkov · Winifred Masterson Burke Med Res Inst · P01 · FY2019 · AG